Health & Medicine
-
Argentina’s Dengue Outbreak Hits Record as Mosquitoes Hatch Earlier
The dengue epidemic that struck Argentina in 2024 did not hit evenly. It carved a line across the country, and that line…
-
Argentina Dengue Outbreak Breaks Records as Government Rules Out Free Vaccine
The 2024 dengue epidemic in Argentina has been deemed the largest dengue outbreak in the country’s history, with a total of 215,885…
-
mRNA Vaccine Flips Glioblastoma Switch in 48 Hours in Early Trial
Florida, May 9, 2024 — cybernewschronicle.com — For seven years, a team at the University of Florida has been working on a…
-
Sugar By-Product Can Temporarily Disable BRCA2 Cancer Protection, Singapore Study Finds
For 40 years, cancer researchers have relied on the two‑hit hypothesis: a person inherits one defective copy of a tumor‑suppressor gene, and…
-
Personalized mRNA Vaccine Triggers Immune Attack on Glioblastoma Within 48 Hours in Small Trial
Asia , May 9, 2024 In a groundbreaking study, researchers have unveiled a new mRNA cancer vaccine capable of triggering the immune…
-
FDA Approves Tovorafenib for Children With BRAF-Altered Low-Grade Glioma
On April 15, 2024, a significant development was made in the treatment of glioma, a type of cancer, with the approval of…
-
More Than 320 US Drugs Went Short in 2024, and Many Shortages Lasted Years
The scope of the 2024 drug shortage in the United States extends far beyond a simple inventory problem, now affecting over 300…
-
Record 323 Active Drug Shortages Hit US in First Quarter of 2024, Pharmacists Say
The United States is currently experiencing an unprecedented scarcity of essential medications, with over three hundred different kinds of drugs and medications…
-
Frederick Appelbaum, Marrow Transplant Pioneer, Chaired Washington’s Andy Hill CARE Fund Board
When Governor Jay Inslee named Frederick R. Appelbaum to the board of the Andy Hill Cancer Research Endowment (CARE) Fund in 2016,…
-
Crisis Text Line Nears 9 Million Conversations in First Decade of Text-Based Crisis Support
Since its founding in 2013, Crisis Text Line has facilitated 9 million conversations, a milestone the organization announced in March 2024. The…
-
Japan Approves Vyloy, First CLDN18.2-Targeted Drug, for Advanced Gastric Cancer
In March 2024, Japanese health regulators gave the green light to zolbetuximab, a monoclonal antibody marketed as Vyloy, for use in patients…
-
American Headache Society Endorses CGRP Antagonists for Migraines
On March 11, 2024, the American Headache Society issued a statement that underscores the evolving landscape of migraine treatment, highlighting the emergence…
-
Eight Children Die and 78 Hospitalized After Eating Sea Turtle Meat on Zanzibar Island
A laboratory analysis has determined that chelonitoxism was responsible for the deaths of nine residents of Zanzibar after they ate sea‑turtle meat,…
-
ALS Patient Brad Smith Becomes Third Person to Receive a Neuralink Brain Implant
On 15 January 2024, Noland Arbaugh, a man living with tetraplegia, demonstrated that he could move a cursor and play an online…
-
Noland Arbaugh Becomes First Human Recipient Of Neuralink Brain Implant
On January 15, 2024, a significant milestone was achieved in the field of health and technology as Noland Arbaugh, an American man…
-
Dengue Outbreak Surpasses 13 Million Cases in Americas
The 2024 dengue outbreak in Latin America and the Caribbean has reached a critical point, with the number of reported infections surpassing…
-
Dengue Spreads Across Central America as Guatemala and Panama Report the Most Deaths
Health authorities in Latin America and the Caribbean are confronting an unprecedented dengue crisis, with 13 million suspected infections reported as of…
-
FDA Approves Casgevy and Lyfgenia, Two Gene Therapies for Sickle Cell Disease
The U.S. Food and Drug Administration announced on December 15, 2023 that it has granted approval to a lentiviral gene‑therapy called lovotibeglogene…
-
CRISPR Therapeutics Holds the First Approved CRISPR Therapy, but Its Stock Is Stuck
On December 15, 2023, the biotechnology industry is abuzz with the recent regulatory approval of a groundbreaking treatment by CRISPR Therapeutics AG,…
-
CGRP Drugs and a Wearable Device Give Migraine Patients New Treatment Options
Migraine attacks often strike without warning, bringing intense pain, light sensitivity and nausea. Traditional acute treatments have been limited, and preventive regimens…
-
Fatty Liver Disease Gets a New Name as MASLD Replaces NAFLD in Global Liver Societies’ Consensus
Under a novel nomenclature agreed upon by three prominent global liver organizations, a prevalent liver ailment is set to undergo a significant…
-
Bahrain Approves DNA-Rewriting Therapy Casgevy
Manama, Bahrain, December 7, 2023 — infopulsetoday.com — MANAMA, Bahrain — The approval came quietly, in a regulatory filing on a Saturday.…
-
Bahrain Approved Casgevy Gene Therapy in 2023, Then Treated Its First Sickle Cell Patient
On December 2, 2023, regulators in the Kingdom of Bahrain granted approval for a gene therapy targeting two inherited blood conditions. The…
Most read
-
Baby & Beyond Maternity Expo in Kuala Lumpur 2026
-
First Human Data on ER-100: What the Sinclair-Linked Eye Gene Therapy Actually Showed
-
AACR Report Details Rapid Progress in Targeted Cancer Therapies and Survival
-
Dexcom CONNECT Study Shows CGM Lowers A1C by 1.6% in Non-Insulin Type 2 Diabetes
-
How Satri-Cel Became the World’s First Approved Solid Tumor CAR-T
-
Experimental Drug Combo Doubles One-Year Survival Rates in Pancreatic Cancer Trial
-
Factor XIa Inhibitor Asundexian Cuts Recurrent Stroke Risk Without Raising Major Bleeding
-
UCSF Scientists Eliminate Deadly Brain Tumors in Mice with B-SYNC Therapy
-
FDA orders class-wide GLP-1 label update for rare eye disease risk
-
Why Oncology Trials Chase Surrogate Endpoints the FDA Ignores
-
Why Achieve Says Most Americans Feel Their Financial Stability is Slipping Away
-
Locking In High Yields: How Current CD Rates Offer Safe Returns Amid Shifting Economic Outlooks
-
Medicare Denies $949 Multi-Cancer Blood Test, Leaving Seniors With Full Bill Until 2029
-
India’s NPPA slashes 137 cancer drug prices by up to 96%, saving ₹3,500 crore annually
-
Inside AbbVie’s High-Stakes Neuro Portfolio and Pipeline Strategy
-
BMS GPRC5D CAR-T Arlo-cel Shows Deep Responses After BCMA Failure
-
Understanding the FDA’s Accelerated Approval of Iberdomide for Multiple Myeloma
-
Rockefeller’s 2141-V11 Trial Shows Complete Remission in Two Metastatic Cancer Patients
-
Ellie Sullivan: Genetic Testing Refused for a Decade, Then Offered After Her Diagnosis
-
Personalized mRNA Cancer Vaccine Succeeds in First Phase 3 Melanoma Trial
-
Indiana University Study Ties Delayed Colorectal Cancer Treatment to Higher Metastasis Risk
-
Study: People Who Drank More Water With Meals Ate More Food, Not Less
-
Why Mornings Are Hardest With ADHD: Late Body Clocks, Poor Sleep and Dopamine
-
Immunotherapy and Genome-Based Vaccines Put the Immune System to Work Against Disease
-
Geneticist John Hardy Proposed Alzheimer’s Amyloid Hypothesis in 1992
























